Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in Greece
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in GreeceClinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Where
- Athens
- Age
- 18 years and over
- People
- 40
- Run by
- National and Kapodistrian University of Athens
See details and how to joinNCT06903130